Abstract
Chapter 7 mentioned that there is a deep relationship between inflammation and cancer, which are regulated by microRNAs (miRNAs). Although inflammation is also implicated in the immune response, both of which can be controlled by miRNAs, autoimmune diseases such as inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) do not usually induce tumorigenesis. Ulcerative colitis (UC) and Crohn’s disease (CD) are commonly included in IBD. UC causes chronic inflammation of the colonic mucosa, and CD features transmural inflammation that occurs in many portions of the gut from the mouth to the anus. RA is also characterized by chronic inflammation as a consequence of sustained synovitis and progressive and irreversible joint damage. Therefore, patients with RA have pain, swelling, and stiffness in multiple joints bilaterally. To further understand the relationship between inflammation and cancer, the pathogenesis of IBD and RA was simulated by miRNA entangling target sorting (METS)/miRNA quantum language and artificial intelligence (MIRAI) using circulating miRNA biomarkers.
Part of the inhumanity of the computer is that once it is competently programmed and working smoothly, it is completely honest.
Asimov I
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmed Hassan E, Abd El-Rehim AS, Mohammed Kholef EF, Abd-Elgwad Elsewify W (2020) Potential role of plasma miR-21 and miR-92a in distinguishing between irritable bowel syndrome, ulcerative colitis, and colorectal cancer. Gastroentrol Hepatol Bed Bench 3:147–154
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581. https://doi.org/10.1002/art.27584
Chen M, Li MH, Zhang N, Sun WW, Wang H et al (2021) Pro-angiogenic effect of exosomal micropRNA-103a in mice with rheumatoid arthritis via the downregulation of hepatocyte nuclear factor 4 alpha and activation of the JAK/STAT3 signaling pathway. J Biol Regul Homeost Agents 35:629–640. https://doi.org/10.23812/20-537-a
Elkoshi Z (2022) Cancer and autoimmune diseases: a tale of two immunological opposites? Front Immunol 13:821598. https://doi.org/10.3389/fimmu.2022.821598
Fujii YR (2023) The microRNA quantum code book. Springer Nature, Singapore
Glant TT, Besenyei T, Kádár A, Kurkó J, Tryniszewske B et al (2013) Differential expressed epigenome modifiers, including aurora kinase A and B, in immune cells of rheumatoid arthritis. Arthritis Rheum 65:1725–1735. https://doi.org/10.1002/art.37986
Griga T, Tromm A, Spranger J, May B (1998) Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease. Scand J Gastroenterol 33:504–508. https://doi.org/10.1080/00365529850172070
Loeys BL, Schwartze U, Holm T, Callewaert BL, Thomas GH et al (2006) Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 355:788–798. https://doi.org/10.1056/NEJMoa055695
Milic V, Jekic B, Lukovic L, Bunjevacki V, Milasin J et al (2012) Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis. Clin Exp Rheumatol 30:178–183
Mudter J, Neurath MF (2007) Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications. Gut 56:293–303. https://doi.org/10.1136/gut.2005.090464
Naviglio S, Arrigo S, Martelossi S, Villanacci V, Tommasini A et al (2014) Severe inflammatory bowel disease associated with congenital alteration of transforming growth factor beta signaling. J Crohns Colitis 8:770–774. https://doi.org/10.1016/j.crohns.2014.01.013
Puig KL, Swigost AJ, Zhou X, Sens MA, Combs CK (2012) Amyloid precursor protein expression modulates intestine immune phenotype. J Neuroimmune Pharmacol 7:215–230. https://doi.org/10.1007/s11481-011-9327-y
Podolsky D (2002) Inflammatory bowel disease. N Engl J Med 347:417–429. https://doi.org/10.1056/NEJMra020831
Rodriguez-Muguruza S, Altuna-Coy A, Castro-Oreiro S, Poveda-Elices MJ, Fontova-Garrofé R et al (2021) A serum biomarker panel of exomiR-451a, exomiR-25-3p and soluble TWEAK for early diagnosis of rheumatoid arthritis. Front Immunol 12:790880. https://doi.org/10.3398/fimmu.2021.790880
Safari F, Damavandi E, Rostamian AR, Movassaghi S, Imani-Saber Z et al (2021) Plasma levels of microRNA-146a-5p, microRNA-24-3p, and microRNA-125a-5p as potential diagnostic biomarkers for rheumatoid arthritis. Iran J Allergy Asthma Immunol 20:326–337. https://doi.org/10.18502/ijaai.v20i3.6334
Sun L, Han Y, Wang H, Liu H, Liu S et al (2022) MicroRNAs as potential biomarkers for the diagnosis of inflammatory bowel disease: a systematic review and meta-analysis. J Int Med Res 50:1–18. https://doi.org/10.1177/03000605221089503
Yan H, Zhang X, Xu Y (2020) Aberrant expression of miR-21 in patients with inflammatory bowel disease: a protocol for systematic review and meta analysis. Medicine 99(17):e19693. https://doi.org/10.1097/MD.0000000000019693
Zhou R, Qiu P, Wang H, Yang H, Yang X et al (2021) Identification of microRNA-15-5p and microRNA-21-5p in feces as potential noninvasive biomarkers for inflammatory bowel disease. Aging 13:4634–4646. https://doi.org/10.18632/aging.202428
Wang H, Chen W, Wang L, Li F, Zhang C et al (2015) Tumor necrosis factor-associated factor 6 promotes migration of rheumatoid arthritis fibroblast-like synoviocytes. Mol Med Rep 11:2761–2766. https://doi.org/10.3892/mmr.2014.3104
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Fujii, Y.R. (2023). Inflammatory Bowel Disease and Rheumatoid Arthritis. In: The MicroRNA 2000 Transformer. Springer, Singapore. https://doi.org/10.1007/978-981-99-3165-1_12
Download citation
DOI: https://doi.org/10.1007/978-981-99-3165-1_12
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-3164-4
Online ISBN: 978-981-99-3165-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)